Increased anti-Mullerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome

被引:111
|
作者
Sir-Petermann, Teresa
Codner, Ethel
Maliqueo, Manuel
Echiburu, Barbara
Hitschfeld, Catalina
Crisosto, Nicolas
Perez-Bravo, Francisco
Recabarren, Sergio E.
Cassorla, Fernando
机构
[1] Univ Chile, Endocrinol & Metab Lab, W Div, Sch Med, Santiago, Chile
[2] Univ Chile, Inst Maternal & Child Res, Sch Med, Santiago, Chile
[3] Univ Chile, Inst Nutr & Food Technol, Santiago, Chile
[4] Univ Concepcion, Sch Vet Med, Lab Anim Physiol & Endocrinol, Chillan 3801061, Chile
来源
关键词
D O I
10.1210/jc.2005-2693
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Anti-Mullerian hormone (AMH) is produced by the granulosa cells and reflects follicular development. Adult women with polycystic ovary syndrome ( PCOS) have increased levels of AMH associated with an excessive number of growing follicles. However, it is not known whether these abnormalities are present before the clinical onset of PCOS. Objective: Our objective was to investigate whether prepubertal daughters of women with PCOS have increased AMH levels. Design: Fourteen female infants (2-3 months old) and 25 prepubertal girls (4-7 yr old) born to PCOS mothers were studied. As a control group, we studied 21 female infants and 24 prepubertal girls born to mothers with regular menses and without hyperandrogenism. The group with PCOS mothers and the control group had normal birth weight and were born from spontaneous singleton pregnancies. Circulating concentrations of gonadotropins, testosterone, androstenedione, estradiol, 17-OH-progesterone, SHBG, inhibin B, and AMH were determined by specific assays. Results: Serum concentrations of AMH were significantly higher in the PCOS group compared with the control group during early infancy (20.4 +/- 15.6 vs. 9.16 +/- 8.6 pmol/liter; P = 0.024) and during childhood (14.8 +/- 7.7 vs. 9.61 +/- 4.4 pmol/liter; P = 0.007). Gonadotropin and serum sex steroid concentrations were similar in both groups during the two study periods, except for FSH, which was lower during childhood in girls born to PCOS mothers. Conclusions: We conclude that serum AMH concentrations are increased in prepubertal daughters of PCOS women, suggesting that these girls appear to show evidence of an altered follicular development during infancy and childhood.
引用
收藏
页码:3105 / 3109
页数:5
相关论文
共 50 条
  • [21] Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome
    Das, M.
    Gillott, D. J.
    Saridogan, E.
    Djahanbakhch, O.
    HUMAN REPRODUCTION, 2008, 23 (09) : 2122 - 2126
  • [22] The relationship between serum anti-Mullerian hormone levels and the follicular arrest for women with polycystic ovary syndrome
    Li, Jian
    Li, Rong
    Yu, Hua
    Zhao, Shuyun
    Yu, Yang
    Qiao, Jie
    SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE, 2015, 61 (02) : 103 - 109
  • [23] Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
    Angela Falbo
    Morena Rocca
    Tiziana Russo
    Antonietta D'Ettore
    Achille Tolino
    Fulvio Zullo
    Francesco Orio
    Stefano Palomba
    Journal of Ovarian Research, 3
  • [24] Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
    Falbo, Angela
    Rocca, Morena
    Russo, Tiziana
    D'Ettore, Antonietta
    Tolino, Achille
    Zullo, Fulvio
    Orio, Francesco
    Palomba, Stefano
    JOURNAL OF OVARIAN RESEARCH, 2010, 3
  • [25] Independent association of serum vitamin D with anti-Mullerian hormone levels in women with polycystic ovary syndrome
    Wong, Ho Yan Queenie
    Li, Hang Wun Raymond
    Lam, Karen Siu Ling
    Tam, Sidney
    Shek, Chi Chung
    Lee, Chi Yan Vivian
    Yeung, William Shu Biu
    Ho, Pak Chung
    Ng, Ernest Hung Yu
    CLINICAL ENDOCRINOLOGY, 2018, 89 (05) : 634 - 641
  • [26] Sibutramine administration decreases serum anti-Mullerian hormone (AMH) levels in women with polycystic ovary syndrome
    Vosnakis, Christos
    Georgopoulos, Neoklis A.
    Armeni, Anastasia K.
    Papadakis, Efstathios
    Roupas, Nikolaos D.
    Katsikis, Ilias
    Panidis, Dimitrios
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2012, 163 (02) : 185 - 189
  • [27] Anti-Mullerian hormone and insulin resistance in polycystic ovary syndrome
    Fonseca, Helena Proni
    Brondi, Renata Suzuki
    Piovesan, Fernanda Xavier
    Miklos, Thomas Gabriel
    Aldrighi, Jose Mendes
    GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (09) : 667 - 670
  • [28] Role of Anti-Mullerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
    Dewailly, Didier
    Barbotin, Anne-Laure
    Dumont, Agathe
    Catteau-Jonard, Sophie
    Robin, Geoffroy
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [29] Anti-Mullerian hormone reflects the severity of polycystic ovary syndrome
    Jacob, S. L.
    Field, H. P.
    Calder, N.
    Picton, H. M.
    Balen, A. H.
    Barth, J. H.
    CLINICAL ENDOCRINOLOGY, 2017, 86 (03) : 395 - 400
  • [30] Pathogenic Anti-Mullerian Hormone Variants in Polycystic Ovary Syndrome
    Gorsic, Lidija K.
    Kosova, Gulum
    Werstein, Brian
    Sisk, Ryan
    Legro, Richard S.
    Hayes, M. Geoffrey
    Teixeira, Jose M.
    Dunaif, Andrea
    Urbanek, Margrit
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (08): : 2862 - 2872